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The pathogenesis of autoimmune disease in certain inbred mouse strains has been 
a subject of thorough study for many years, due to its possible relationship to similar 
syndromes in man. Despite such scrutiny, however, no common etiologic denominator 
that  may signal  the  onset  of these  disease  processes  has  yet  been  found.  In recent 
years, much attention  has  been  given to the  analysis of abnormal  function among 
various immunocompetent cell types in such mice. The separation of murine lympho- 
cytes into T  and B cells and their subsets is based on the expression of certain surface 
markers which, in turn, have been linked to distinct biological functions. Thus, B cells 
interact with antigens via surface immunoglobulin (Ig)  molecules and communicate 
with other cells  via Fc and complement (C)  receptors (1). Moreover, subpopulations 
of B  cells  of different  Ig isotypes  can,  in  certain  instances  modulate  the  immune 
response of one another so that a coordinated response is achieved. Certain subsets of 
T  lymphocytes act,  respectively, to facilitate  or to  diminish  immune responses  (2). 
These subsets express on their surfaces different Ly alloantigens and/-region-associ- 
ated  (Ia)  antigens  (3, 4).  In addition, overall internal self-regulation of the immune 
system may also involve the functional effects of anti-idiotype reactions at  both T- 
and B-cell surfaces (5). 
This complex interplay of distinct cell subsets and molecular products of such cells 
must obviously retain a critical integrity for the system to function normally. Pertur- 
bations among the cellular components may, therefore, be associated with the onset 
ofautoimmune reactivity in experimental animals as well as man. In order to examine 
the  relationship  of such potential  perturbations  to autoimmune manifestations,  we 
have conducted a  thorough analysis of the phenotypic expression of various surface 
markers on lymphoeytes from lymphoid organs of New Zealand mice  (NZB,  [NZB 
×  NZW]Fx) and of the newly described MRL/I, MRL/n, and BXSB strains  (6-8). 
Particular attention has been paid to the development of alterations in the T- and B- 
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cell compositions of these mice as their genetically characteristic autoimmune disease 
appears.  Furthermore,  we  assessed  whether  phenotypic abnormalities,  if any,  of T 
and B  cells were identical or different among the five autoimmune murine strains. 
In this report, we describe the frequency and number of cells bearing surface Ig, C 
receptors, IgG Fc receptors, 0-antigen, Ly alloantigens, and suppressor cell Ia antigens 
in these mice. We also determined the various isotypes of Ig expressed on  B  cells in 
newborn  and  adult  animals.  The  results  indicate  that  all  five autoimmune  mouse 
strains  manifest  alterations  in  their  T-  and  B-cell compositions  with  age  and  the 
appearance of disease. However, these alterations are not the same in all five strains. 
Materials  and  Methods 
Mice.  C3H/St~H-2k), C57BL/6 (H-2b), BALB/c (H-2a), NZB (H-2a),  (NZB  ×  NZW)F1, 
(NZB ×  W) (H-2  /  ) mice are bred and maintained in our colony. The inbred strains BXSB 
(H-2b), MRL/l (H-2k), and MRL/n (H-2 k) were developed by Dr. E. M. Murphy and originally 
obtained from The Jackson Laboratories, Bar Harbor, Maine, but were bred and maintained 
thereafter in our colony. The age and sex of the animals employed is indicated in the results 
section. 
Cells.  All cell suspensions were prepared at room temperature. Cells from spleens, mesenteric 
lymph  nodes,  and  thymuses  were  prepared  by  passage  through  a  stainless steel  screen  in 
minimum essential medium buffered with 25 mM Hepes (Grand Island Biological Co., Grand 
Island, N. Y.)  and containing 5% fetal bovine serum (thereafter referred to as medium). Bone 
marrow cells were extracted from the femurs by cutting one end and flushing the cells out the 
other end with a syringe. The cell clumps were then dissociated by being pipetted up and down 
several  times.  Peripheral  blood  lymphocytes  were  obtained  from  heparinized  blood  after 
dextran sedimentation and  Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway, N. J.) centrifugation. All cell preparations were allowed to settle to remove 
large aggregates. Erythrocytes were lysed with 0.17  M  NH4CI  (4°C,  10 min), and nucleated 
cells were washed twice with medium. Cell suspensions were then kept at 37°C for 1 h to allow 
for the release of any cytophilic antibodies absorbed in  vivo and  washed again. Cells were 
counted, and viability was determined by trypan blue dye exclusion. Viabilities ranged from 
75 to 90%  (spleen), from 85 to 95%  (lymph node), and >90%  (all others). Newborn mice were 
killed by decapitation, their spleens obtained for preparation of cell suspensions as above, and 
the peritoneal cavity was carefully examined to determine the sex of each individual. 
Antisera.  A  fluorescein isothiocyanate (FITC)l-conjugated polyvalent rabbit antiserum to 
mouse  Ig and  a  rhodamine  (R/J)-conjugated rabbit  antiserum  to  mouse brain were kindly 
provided by Dr. S. Russell (Scripps Clinic and Research Foundation). The Fab'2 fractions of 
both antisera were employed (9). 
The preparation and use of Ly 1.2, Ly 2.1, Ly 3.2 and Thy 1.2 antisera (generously supplied 
by Dr. F. W. Shen, Memorial Sloan-Kettering Cancer Center, N. Y.)  has been described (10, 
11). These antisera were absorbed with spleen cells from congenic strains of mice and extensively 
tested to verify their specificity on target cells. The Ly 2.1 antiserum was additionally absorbed 
with BALB/c spleen cells before use. 
FITC goat anti-mouse IgG1 and IgG2 (IgG2a and IgG2b combined) antibodies were obtained 
from Meloy Laboratories, Inc., Springfield, Va. Anti-mouse IgA serum was raised in rabbits 
immunized with TEPC 15 myeloma protein (IgA,k). This antiserum was absorbed on Sepharose 
(Pharmacia-Fine Chemicals,  Div.  of Pharmacia  Inc.)-bound  MOPC  315  myeloma protein 
(IgA,)~) and conjugated with FITC by a dia'lysis procedure (12). Antiserum to IgM was raised 
in rabbits injected with MOPC  104E  myeloma protein (IgM,~). The antiserum was affinity 
purified on Sepharose-bound ABPC22 myeloma protein (IgM,g). This antiserum was further 
absorbed with Sepharose-bound IgG and IgA to render it specific and conjugated with FITC. 
Rabbit anti-mouse IgD (13), a gift from Dr. R. L. Coffman (Stanford University), was absorbed 
x Abbreviations used in this paper: BSA, bovine serum albumin; DNP,  dinitrophenyl;  FITC, fluorescein 
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twice with an equal volume of MRL/I lymph node cells (>95% of T origin). F(ab')2 fragments 
were prepared from the IgG fraction of this antiserum by pepsin digestion and Sephadex G-200 
chromatography. Antibody made in sheep against rabbit IgG was affinity purified on Sepha- 
rose-bound F(ab')z of rabbit IgG, and then digested with pepsin and chromatographed on a 
Sephadex G-200 column. This F(ab')2 anti F(ab')2 antibody was fluoresceinated as above. 
Anti-l-J  k serum  (3R  anti-5R)  was  kindly provided by Dr. J.  Silver (Scripps Clinic and 
Research Foundation), and anti-l-J  b (5R anti-3R) serum was from Doctors M. E. Dorf and B. 
Benacerraf (Harvard Medical School, Boston, Mass.). 
Enumeration of Surface Ig- and O-Antigen-Bearing Cells.  The frequency of Ig-and 0-positive cells 
in the various ce!l suspensions was ascertained simultaneously by using a  mixture of FITC- 
F(ab')2 anti-mouse Ig antibody and R6-F(ab')2 anti-mouse brain antibody. The staining was 
done as follows: 2  ×  l0  s nucleated cells were incubated (4°C, 30 min) with 50 #1 total volume 
of equal parts of a  1:200 final dilution of FITC F(ab')2 anti mouse Ig antibody and a  1:8 final 
dilution of R6 F(ab')2 anti-mouse brain antibody. Antisera were diluted in medium containing 
0.1%  NaNa. Subsequently, the cells were washed three times with cold medium, centrifuged, 
and the pellets were resuspended in  10 #1 phosphate-buffered saline containing 10% Patho-o- 
cyte (Miles Laboratories Inc., Miles Research Products, Elkhart, Ind.). Drops were placed on 
a slide under a coverslip, sealed, and kept on ice until viewed. These cells were examined under 
a  Zeiss microscope  (Carl  Zeiss,  Inc.,  N.  Y.)  using  a  vertical  illuminator equipped  with  a 
combination of excitation and barrier filters for the selective visualization of either FITC or 
Ri5 stains. Approximately 300 cells were counted, and the percent of FITC-(B cells) and RI~-(T 
cells) positive cells was recorded. 
Enumeration of C3- and IgG Fc Receptor-Bearing Cells.  C3 receptor-bearing cells were assessed 
as described (14)  using sheep erythrocytes sensitized with IgM rabbit hemolysin and reacted 
with  C5-deficient serum  obtained  from  B10.D2/old  mice  (EAC).  These  intermediates are 
immune adherence negative (14) and, therefore carry C3d but not C3b. 
Receptors for IgG Fc, which are present on subsets of both T  and B cells as well as on other 
unclassified lymphocytes (15), were assessed two ways: (a) rosetting ofox erythrocytes sensitized 
with an optimum amount  of the IgG fraction of a  rabbit anti-ox erythrocyte antibody (16) 
(EA); and (b) uptake of soluble rabbit anti-dinitrophenyl (DNP)-bovine serum albumin (BSA) 
plus DNP-human gamma globulin (HGG) complexes at a fourfold antigen excess and staining 
with FITC sheep anti-rabbit Ig (15). 
Analysis of Cell-Surface Ig Isotypes on B  Cells.  The percentages of splenic B cells from adult 
animals bearing most isotypes of murine Ig (IgG1, IgG2, IgM, IgA, and IgD) were determined 
using direct or indirect immunofluoreseence followed by processing in a cell sorter. No attempts 
were made to determine cells bearing combinations of isotypes on their surface. 
IgG1, IgG2, IgA, and IgM-bearing cells were detected by direct immunofluorescenee. In brief, 
spleen cells were subjected to Ficoll-Hypaque centrifugation to remove dead cells; then aliquots 
of 2  ×  10  s cells were incubated (4°C, 30 min) with optimum amounts of the isotype specific 
FITC-conjugated antisera. Cells were then  washed  three times in  medium containing 0.1% 
NaNa and brought to 2  X  106 cells/ml before being subjected to cell sorting. IgD-bearing cells 
were detected by indirect immunofluorescence. 4 million Ficoll-Hypaque-separated cells were 
incubated (4°C, 30 min) with an optimum dilution of F(ab')2 rabbit anti-IgD antibody, washed 
three times, stained with FITC-conjugated F(ab")2 sheep anti-rabbit F(ab')2 antibody (4°C, 30 
brought to 2  ×  10  cells/ml.  min), washed again, and  6 
FITC-stained cell suspensions were counted and sorted on the basis of bright fluorescence 
using the Becton-Dickinson FACS-III cell sorter (BioQuest, BBL, & Falcon Products, Becton, 
Dickinson, & Co., Cockeysville, Md.) as previously described (17).  Bright cells were contami- 
nated with up to 1% of dull cells, and dull cells were contaminated with up to 0.2% of bright 
cells as judged by repeat analysis of sorted cells in the regular fluorescence microscope. The 
frequencies of neonatal splenic B cells bearing surface IgM and/or surface IgD were determined 
as above using direct and indirect immunofluorescence techniques, respectively, but employing 
the regular fluorescence microscope instead of the cell sorter. 
Analysis of Ly-Subclass Distribution.  The phenotype ofT-cell surface allo-antigens is (a) H-2 k, 
Ly 1.2, Ly 2.1, Ly 3.1, Thy 1.2, and Tla  b for MRL/I; and (b) H-2  b, Ly 1.2, Ly 2.2, Ly 3.2, Thy 
1.2, and Tla  b for BXSB mice (6). The percentage of 0-positive cells in lymph nodes from MRL/I 
and C57BL/6 mice were estimated using a Thy  1.2 antiserum and selected rabbit serum as a THEOFILOPOULOS ET AL.  519 
source of complement in a two-stage cytotoxicity assay (11). Cell viability was determined  by 
trypan  blue  exclusion.  The  proportions  of lymph  node  cells expressing  one  or  more  Ly 
components were similarly estimated  after exposure to various Ly antisera as well as combina- 
tions of two of these antisera,  according to a protocol detailed  previously (18). 0-positive cells 
that did not express Ly alloantigens  (Results) were designated  as Ly null T cells. 
Detection ofI-J Alloantigen-Bearing Cells.  Spleen cells from MRL-I, MRL-n, and BXSB mice 
and histocompatible  normal C3H and C57BL/6 mice of  various ages were examined. 50 million 
spleen cells were obtained after Ficoll-Hypaque  centrifugation  and incubated with an optimum 
dilution of FITC-conjugated rabbit anti-mouse Ig. Cells were washed three times with medium 
containing NaNa, brought to 2 ×  106 cells/ml  and subjected to cell sorting. Dull cells (>95% 
were T  cells as judged by positive stainings with  R~i-conjugated anti-mouse  brain antibody) 
were collected. 2 million isolated T cells from each of the above strains were incubated (4°C, 30 
min)  with  an  optimum  amount  of mouse  anti-I-J  k antiserum  (MRL,  C3H)  or  anti-I-J  b 
antiserum  (BXSB, C57BL/6) and washed three times with medium containing NAN3. Control 
suspensions were similarly treated  with medium or normal mouse serum. Then the cells were 
stained  (4°C, 30 min) with an optimum dilution  of FITC-rabbit anti-mouse  Ig antibody and 
washed three times. FITC-positive  cells were determined  under the fluorescence microscope as 
above. Percentages of I-J positive cells were corrected for surface Ig-bearing cells contamination 
by subtracting the percentage  positive cells in control suspensions (<1%). 
Results 
Characteristics of the Autoimmune Syndromes.  The age-sex correlations of disease man- 
ifest  in the various autoimmune strains can be briefly summarized as follows (7, 8): 
NZB mice of both sexes have a  50% mortality at 21-23 mo old. In NZB  ×  W  mice, 
the disease appears in the female around the 6th mo with 50% mortality at 8.5 mo 
and a 90% mortality at  12.8 mo. The male hybrid develops his disease after yr of age 
with a  50% mortality at ~15 mo of age. The MRL mice have been subdivided into 
two similar strains sharing 89% of their genomes. The MRL/I strain with the lpr (lpr 
--  lymphoproliferation)  gene  is  characterized  by massive  lymphoproliferation and 
early disease (50% mortality in both sexes at a little over 5 mo and 90% mortality by 
6.8 mo in the female and 8.8 mo in the male). The MRL/n strain,  without the lpr 
gene, is characterized by late disease with 50% mortality at  17 and 23 mo for female 
and male, respectively, and 90% mortality at 23 and 27 mo. The male BXSB mouse 
begins to show signs of his disease by the 3rd-4th mo, with 50% mortality at 5 mo and 
90% mortality at 8 mo. In this strain, the female first appears ill shortly after  1 yr of 
age with 50% mortality at  15 months and 90% mortality at 2 yr. 
Enumeration of B  Cells.  The frequencies of nucleated cells  bearing surface Ig and 
C3d receptors in the various lymphoid organs of young and old mice of strains with 
the systemic lupus  erythematosus  (SLE)-like syndromes and  one normal  strain  are 
shown in Figs.  1 and 2. The absolute numbers of these cells in spleens and mesenteric 
lymph nodes are presented in Table I. Generally, except for the old BXSB male mice, 
all strains examined had normal organ distributions of surface Ig-bearing cells, being 
higher in the spleens than in the lymph nodes and peripheral blood. In the normal 
C57BL/6 mice, the frequencies and absolute numbers of these cells  remained stable 
with  age.  NZB and  NZB  X  W  mice had  reduced frequencies and  numbers of Ig- 
bearing cells in spleens and lymph nodes with advanced age and disease.  In MRL/I 
mice  there  was  a  similar  substantial  reduction  in  frequencies,  but  not  absolute 
numbers, of these cells,  especially in lymph nodes, with advancing disease.  MRL/n 
mice equaled the normal C57BL/6 on all counts. In contrast, BXSB male mice, but 
not females (data not shown), had a substantial  increase in frequencies and absolute 520 
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Fro.  1.  Surface Ig-bearing cells in lymphoid organs of normal and autoimmune mice. Each column 
represents the mean  + SD obtained from three animals. Dotted columns depict animals 1 mo old 
and hatched columns depict animals of 8 mo old, except MRL/1 and BXSB mice where animals of 
1 and 4½-5 mo were examined. S = spleen, T =  thymus, BM = bone marrow, MLN =  mesenteric 
lymph nodes, PBL -  peripheral blood lymphocytes. 
numbers  of Ig-bearing cells  associated  with  advanced  disease.  As all  the  mice with 
autoimmune  manifestations  aged,  the  frequency  of Ig-bearing cells  in  the  thymus 
increased.  In general,  reductions  or increases  in  frequencies  of Ig-bearing cells  ap- 
peared to be reflected equally in spleens and lymph nodes. 
The frequencies of the C3d receptor-bearing cells in lymphoid organs, except bone 
marrows,  were  lower  than  those  of the  Ig-bearing cells  in  all  mice  tested  (Fig.  2). 
However,  the  general  trends  seen  with  the  surface  Ig-bearing  cells  were  similarly 
reflected in the C  receptor-bearing cell populations, with the notable exception of the 
BXSB male mice. There was no significant difference between young and old normal 
C57BL/6 mice. In NZ mice, and more prominently in male BXSB mice, the frequency 
of C3d  receptor-bearing  cells  was  higher  during  youth  than  in  normal  mice,  but 
declined with advanced age and disease. MRL/I, but not MRL/n, mice also exhibited 
a  reduced frequency of C3d receptor-bearing cells with advanced disease, consistent 
with the reduced frequency of Ig-bearing cells. 
Ig Isotypes on the Surfaces of Ig-Bearing  Cells.  The frequencies of IgG 1-bearing splenic 
cells  were  5%  or less  in  all  strains  tested  at  all  ages  (Table  II). From  5-19%  of the 
spleen cells in the various murine strains had IgG2 on their surfaces. In general, mice 
with  autoimmune  manifestations  had  a  higher  frequency  of these  cells  than  the 
normal  mice,  especially  in  later  life.  Similarly,  autoimmune  mice  had  many  fold 
higher percentages  of IgA-positive cells,  although  the  frequencies were <10%  in all 
cases.  Many of the cells, as expected, were positive when stained with anti-IgM and 
anti-IgD sera.  In all  young mice,  the  proportions of IgM-positive cells  and  of IgD- 
positive  cells  were  similar  except  in  the  MRL/1  where  IgD  cells  were  twice  as 
numerous as IgM. However, in NZB and NZB  ×  W  females and BXSB male mice, THEOFILOPOULOS  ET  AL. 
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the ratio of IgM- over IgD-bearing cells increased with age.  In contrast,  in  MRL/I 
mice, there was a decrease in ratio of IgM- over IgD-bearing cells with increasing age. 
Sequential Expression of Ig Isotypes on Developing B Lymphocytes.  Spleen cells of newborn 
mice were examined sequentially from the  1st  to  7th d  after birth  for expression of 
IgD and IgM. The results are presented in Table III. The time of appearance and the 
frequencies of cells bearing IgM or IgD in the autoimmune mice were similar to those 
observed in two normal strains. IgM-bearing cells were present on spleen cells obtained 
immediately after birth,  whereas  IgD-bearing cells  appeared  for the  first  time 3  d 
after birth. 
Enumeration ofIgG Fc Receptor-Bearing Cells.  The proportion of these cells as shown 
in Fig. 3 and Table IV were similar in a  normal strain and the autoimmune murine 
strains while young. However, in all mice with SLE-like syndromes, but not the one 
normal strain, the frequencies of these cells decreased with advanced age and disease. 
Enumeration of T Cells.  The proportions and absolute numbers of nucleated cells in 
the various lymphoid organs expressing 0-antigen are presented in Fig. 4 and Table 
I. In general, there were normal organ distributions of these cells, being higher in the 
lymph nodes  than  the spleens of all animals tested.  As the normal  C57BL/6  mice 
aged, their T-cell values remained stable. However, there was a decline in numbers of 
these cells in the lymphoid organs of NZB and NZB  ×  W  females and BXSB male 
mice  with  advanced  age  and  disease.  MRL/n  mice  showed  a  modest  increase  in 
frequencies  and  absolute  numbers  of these cells with  age.  In MRL/I  mice, a  clear 
increase in T-cell frequencies and massive increase in absolute numbers was observed 
with  advanced disease.  More than 90% of the cells in the enlarged lymph nodes of 
these mice were positive for 0-antigen, indicating that the lymphadenopathy seen in 
these mice was largely due to T-cell proliferation. 
Enumeration  of Ly  Alloantigen-Bearing  Cells.  The  frequency  of Lyl ÷,  Ly23  +,  and 522  LYMPHOCYTE  MARKERS  IN  SLE  MICE 
TABLE  I 
Enumeration of B and T cells in Lymphoid Organs of Normal and Autoimmune Mice 
Spleen  MLN* 
Strain  Age  Total No.  No. slg  ÷  No. 0  + cells  Total No.  No. slg  ÷  No. 0  + cells 
cells  cells  (X I0  -6)  (X I0  -8)  (X I0  -6)  (X I0  -~)  (X I0  -s)  (X 10  -6  ) 
mo 
C57BL/6 ~?  1  905  47  33  11  4  6 
8  105  59  36  14  6  7 
NZB ~  !  83  39  36  15  5  9 
8  90  25  23  17  4  8 
(NZB  ×  NZW)F~ ~  1  100  51  41  15  5  9 
8  110  35  28  22  5  9 
BXSB d  1  65  19  39  17  4  10 
5  215  135  38  32  19  7 
MRL/n ~  1  50  26  16  30  8  19 
8  70  27  31  43  8  33 
MRL/I ~  1  52  19  21  30  7  7 
4.5  310  52  226  610  12  579 
* MLN, mesenteric lymph nodes. 
$ Numbers represent the mean of three animals. 
Ly123  ÷ T-cell subclasses in the spleen cell populations of female NZB and BALB/c 
mice of increasing ages have been reported by Cantor et al. (19). We have determined 
the various Ly subsets in lymph node cells of MRL/I females at early and advanced 
ages and compared them to similar data from  12-wk-old normal C57BL/6 females. 
The results shown in Fig. 5 are expressed as a percent of total cells recovered from the 
nodes and as a percent of the 0-antigen-bearing cells in that population expressing the 
various Ly phenotypes. In  the  C57BL/6  females and  young MRL/1  female mice, 
distributions of the two large subsets, the Ly 1  ÷ and the Ly 123  ÷, and the much smaller 
Ly23  +  subset  were  quite  similar.  The sum  of Lyl  +,  Ly23  +,  and  Ly123  ÷ cells was 
similar  to  that  of 0-antigen-bearing  cells  in  C57BL/6  and  young  MRL/1  mice. 
However, an unexpected and striking observation in MRL/I mice of advanced age 
and disease was the extreme reduction in numbers of Ly123  + cells and Ly23  ÷ cells 
compared to the young animals and a concomitant increase in the percentage of 0 +, 
Ly-, or null cells. The accumulation of Ly null cells in these mice followed a straight 
line with age (Fig. 6). 
Enumeration  of Ia  Antigens  Coded by  the  I-J  Subregion in  Splenic  Lymphocytes.  The 
percentages of I-J positive T  cells isolated from the spleens of four immunologically 
normal  (C3H,  MRL/n,  C57BL/6,  and  BXSB  females)  and  the  two  autoimmune 
strains (MRL/I, BXSB males) of young and advanced age are presented in Table V. 
No significant reduction of cells bearing Ia antigens coded by the l-J subregion of the 
H-2 gene complex was observed in any of the mice tested. However, MRL/I mice of 
advanced age showed a high frequency and absolute number of these cells. 
Discussion 
Many speculations have been raised concerning the extent and types of functional 
lymphoid  cell  abnormalities  that  might  play  important  pathogenic  roles  in  the 
development  of  autoimmune  disorders  in  both  experimental  animals  and  man. Surface lg lsotypes 
THEOFILOPOULOS  ET  AL. 
TABLE II 
of Splenic  B  Cells from  Normal  and Autoimmune  Mice 
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Antiserum 
C57BL/6 ~?  NZB 2  NZB  X  W  ~? 
1  8  1  8  1  8 
mo  mo  mo  mo  mo  mo 
Anti-IgG1  1.7"  1.6  3.8  3.8  2.7  5.8 
Anti-IgG2  5.6  7.8  3.4  8.3  5.5  12.0 
Anti-IgA  0.7  0.9  2.5  6.7  3.2  5.2 
Anti-IgM  38.0  31.7  34.2  23.8  36.2  31.8 
Anti-IgD  42.5  29.0  37.1  10.0  37.6  13.0 
BXSB ~  BXSB S  MRL/n ~  MRL/I 
Antiserum 
1  8  1  8  1  8  1  4.5 
mo  mo  mo  mo  mo  mo  mo  mo 
Anti-IgG 1  1.2  2.8  2.3  4.6  2.1  4.1  2.0  1.7 
Anti-IgG2  7.0  12.0  11.5  18.7  6.1  12.1  5.3  11.5 
Anti-IgA  3.3  7.2  2.8  ND§  9.5  2.5  2.0  3.1 
Anti-IgM  23.4  27.2  22.4  48.0  32.8  30.3  9.4  2.4 
Anti-IgD  24.2  23.9  19.4  10.2  34.3  29.0  22.5  18.0 
* Numbers represent the mean percent cells positive for three animals. 
§ ND, not determined. 
Because the predominant phenotypic expression of autoimmunity shows clear overlap 
from one individual (or inbred strains in the case of experimental animals) to another, 
one might  logically expect the existence of certain basic common pathways  to the 
clinically relevant end point. To date, however, this has not been borne out despite 
considerable evaluation over many years. 
In  this  study, we  have analyzed,  in  varying aspects,  the distribution,  frequency 
relationships, ontogenic changes, and  defined genetic markers of lymphoid cells in 
five different kinds of mice manifesting autoimmune syndromes and normal nonau- 
toimmune counterparts.  Although  varying types of distribution  and  frequency ab- 
normalities were detected in certain of these strains, particularly in association with 
advanced age and disease onset, the most striking message derived from these analyses 
is the diversity of such abnormalities among the different experimental mouse strains. 
This makes it clear, therefore, that despite similarities in autoimmune manifestations 
that  may exist from one individual  to the next, the pathogenesis of such disorders 
most probably includes a spectrum of primary or secondary lymphoid cell abnormal- 
ities. 
Thus, frequencies and absolute numbers of B cells decrease substantially as non-Ig, 
non-0-bearing cells increase in spleens and lymph nodes of aging, sick NZB and NZB 
×  W  mice. Stobo et al. (20) demonstrated a similar low frequency of B cells in NZB 
and NZB  X  W  mice of advanced age; this is not due to alterations in the cell surface 
that renders Ig determinants less accessible for binding by antibody. They postulated 
that the decrease in B cells indicated either (a) an abnormality in the capacity of Ig 
negative progenitor cells  (possibly through a  defect in  the T-cell compartment)  to 
progress along normal pathways which involve the acquisition of surface Ig determi- 
nants, or (b) unusual numbers of B cells in transition between the precursor state and 
the state of active secretion of Ig and, therefore, low in quantities of surface Ig (21). 524  LYMPHOCYTE  MARKERS IN  SLE  MICE 
TABLE III 
Ontogeny of Splenic B Cells Bearing Surface IgM or Surface IgD in Normal 
and Autoimmune Mice 
Strain*  Age 
C57BL/6 9 
BALB/c 
NZB 
(NZB  X NZW)F1 2 
BXSB 
BXSB  c~ 
MRL/I 9 
Cells bearing 
sIgM  sIgD 
d  % 
1  3.4  <0.01 
2  4.1  <0.01 
3  9.8  1.9 
5  10.7  5.3 
7  12.2  7.9 
1  2.8  <0.01 
2  6.4  <0.01 
3  7.2  0.8 
5  9.8  2.7 
7  10.9  5.6 
1  5.2  <0.01 
2  5.7  <0.01 
3  7.8  2.4 
5  8.4  3.5 
7  11.0  7.0 
1  3.1  <0.01 
2  4.7  <0.01 
3  7.2  2.0 
5  7.8  5.1 
7  7.9  7.2 
1  6.8  <0.01 
2  7.0  <0.01 
3  7.2  1.8 
5  9.0  4.6 
7  12.7  5.5 
1  3.2  <0.01 
2  6.3  <0.01 
3  7.4  0.8 
5  12.1  2.6 
7  18.2  5.5 
1  4.7  <0.01 
2  8.3  <0.01 
3  8.8  2.6 
5  12.0  5.1 
7  13.1  8.1 
* A pool of nucleated cells from three spleens at the various time intervals was 
examined. 
In view of the recent findings of Izui et al.  (22), Moutsopoulos et al.  (23)  and our own 
unpublished observations  2 indicating high production of Ig and large numbers of Ig- 
2 Theofilopoulos,  A.  N.,  R.  A.  Eisenberg,  and F. J.  Dixon.  Ig-secreting  cells in  mice with SLE-like 
syndromes.  Manuscript in preparation. THEOFILOPOULOS  ET AL.  525 
TABLE IV 
IgG Fc-Receptor-Bearing Cells in Lymphoid Organs of Mice with SLE-Like 
Syndromes as Detected by Uptake of Soluble Immune Complexes 
Strain  Age 
IgG Fc-receptor-bearing  cells 
Spleen  MLN* 
mo  % 
NZB ~  I  48:~  33 
8  32  23 
(NZB X NZW)Ft ~  1  73  41 
8  39  30 
BXSB ~  l  48  59 
5  34  22 
MRL/I ~  1  33  34 
4.5  21  12 
* MLN, mesenteric  lymph nodes. 
~: Numbers represent the mean of three animals. 
secreting  cells  in  spleens  of older  mice,  the  loss  of surface  Ig  due  to  advanced 
maturation is the more likely explanation. 
Unlike  NZ  mice,  BXSB  male mice with  advanced  disease  exhibit  an  increased 
frequency and number of surface Ig-bearing cells. As reported (6-8), BXSB male mice 
develop spontaneous autoimmune disease characterized by moderate lymphadenop- 
athy and splenomegaly, hypergammaglobulinemia, immune complex glomerulone- 
phritis, and various kinds of autoantibodies.  Histologically, the lymphoproliferation 
shows a predominance of lymphocytes with admixed plasma cells and histiocytes and 
appears from the present studies  to be of B-cell origin.  As Murphy and Roths  (24) 
noted, this syndrome closely resembles the nonneoplastic hyperimmune proliferation 
of B  cells recently described  in man as immunoblastic lymphadenopathy  (25).  The 
fact that BXSB males, contrary to NZ mice, have a high frequency of Ig-bearing cells 
even late in life may be related to their tendency toward lymphoproliferation and/or 
to produce less mature B cells. In fact, BXSB male mice have fewer Ig-secreting cells 
in  their  spleens  than  NZ  mice,  2 as  tested  by a  reverse hemolytic plaque  assay.  In 
contrast to BXSB mice, as MRL/I mice advanced in age and disease, low frequencies, 
but  not  absolute  numbers of B  cells, characteristically accompanied massive T-cell 
proliferation. 
The results of our experiments indicate that Ig isotypes appear on the surfaces of 
spleen cells from mice with autoimmune disease in the same sequence as in normal 
mice (26); IgM is present at birth and IgD appears 3 d later. Therefore, autoimmunity 
is probably not caused by some irregularity in the generation of B-cell isotype diversity 
associated with resistance to induction of self-tolerance. This latter consideration arises 
from work by other investigators who showed that murine B cells from bone marrow 
(27)  and  neonatal  spleens  (28,  29)  are more readily tolerized  to thymus-dependent 
antigens than splenic B cells from adults, and that maturatior~al decrease in suscep- 
tibility  to  tolerance  induction  is  determined  by  the  acquisition  of  surface  IgD 
determinants  (30-32). 
We studied the expression of surface Ig isotypes in spleen cells of aging autoimmune 
mice without regard to combinations on a  single cell and found a  high frequency of 
IgG-bearing cells. This finding may indicate advanced maturation of B cells in these 526  LYMPHOCYTE MARKERS IN SLE MICE 
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mice. Furthermore, because IgG-bearing cells differentiate to IgG-secreting cells and 
can depress IgM production (33, 34), our finding is in accord with the observed switch 
of anti-DNA antibodies in New Zealand mice from IgM to IgG late in life (35)  and 
with the switch by cells of all autoimmune strains from IgM to IgG secretion as the 
host  ages  and  manifests  disease. 2 The  frequencies  of IgG-bearing  cells  were  not 
artificially elevated  by the  binding  of rabbit  antiserum  via  Fc  receptors, because 
F(ab')2 reagents produced similar results. Nor was the mouse IgG passively absorbed, 
because  incubation  at  37°C  did  not  reduce  numbers  of IgG-positive  cells  (36). 
Additionally, NZ and BXSB mice of advanced age and disease have a high ratio of 
IgM/IgD. Because >90% of B cells in normal adult animals bear both IgM and IgD 
(37,  38),  the cells we examined in  the sick, older animals  are  probably driven  by 
antigenic stimulation to lose their surface IgD (39). Apparently, surface IgD was also 
lost preferentially during LPS-induced activation of B lymphocytes from immunolog- 
ically  normal  mice  (40)  and  during  aging  of NZB  mice  (41).  Cohen  et  al.  (41) 
concluded  that  the  increased  ratio  of surface  IgM  to  IgD  in  NZB  mice  indicates 
advanced  maturation  possibly  due  to  polyclonal  activation  and  is  not  due  to  a 
maturational  arrest  nor acquisition of IgM  anti-thymocyte antibodies from serum. 
Compared to NZ and BXSB mice, MRL/1 mice manifested a  higher percentage of 
IgD-bearing than  IgM-bearing cells and,  in  general,  have fewer mature  B  cells as 
indicated by their lower frequencies of splenic Ig secreting cells. 2 These IgD positive 
cells  may represent  immature  IgG memory cells that  give rise to secretion of IgG 
antibodies of low avidity (39). However, the Ig-secreting cells appear to be exception- 
ally productive as shown by the exceedingly high levels of IgG in sera of old MRL/I 
mice (7). 
Young BXSB  and  NZ  mice have more C3d  receptor-bearing cells  than  normal 
mice, again suggesting hastened maturation because the C3d receptor appears late in THEOFILOPOULOS  ET AL.  527 
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B-cell development (42,  43).  However, the frequency of these cells fall markedly with 
advanced  age and  disease.  This  decreased  frequency  of the  EAC-rosetting cells  as 
disease  advanced  may  suggest  occupation  of C3d  receptors  by  C-fixing  immune 
complexes, shown by ourselves to be present in the sera of these mice late in life (7). 
We (44) and Eden et al. (45) have also shown that soluble C-fixing immune complexes 
bind to C3b and C3d receptors on B cells, and that bound complexes are not easily 
removed from these receptors even after prolonged incubation. In addition, C receptor- 
bearing cells may be eliminated from the circulation when bound to soluble complexes. 
Autoimmune mice lose IgG Fc receptor-bearing cells as they age. This was dem- 
onstrated by two techniques, namely rosetting with particulate complexes and binding 
of soluble  complexes.  The  results  were parallel,  but  not  quantitatively  equivalent, 
possibly  due  to  the  different  accessibilities  of  the  Fc  receptors  by  soluble  and 
particulate complexes. Although the IgG Fc receptor appears on B and T  cells as well 
as some unclassified lymphocytes, its role has not been fully elucidated.  Fc receptor- 
bearing  cells  can  be  mediators  of  antibody-dependent  cytotoxicity  (1.5) or  may 
function as regulators of antibody production at the B-cell level (46,  47).  Moreover, 
Stout et al.  (48)  found that murine Fc receptor-positive T  cells responded to concan- 
avalin A, contained  the  differentiated  cytotoxic effector cells in cell-mediated lym- 
pholysis and included amplifier T  cells but not helper T  cells. The decline of IgG Fc- 
receptor positive cells in autoimmune mice with advanced disease may result because 
immune complexes occupy the receptors or because these cells leave the circulation 
after binding immune complexes. 
In terms of T  cells,  there is a  moderate decrease in  frequency and numbers of T 
cells in NZ mice with age and onset of disease. Other workers obtained similar results 
(49, 50). Shirai et al. (51) and Klassen et al. (52) attributed the reduction ofT cells to 528  LYMPHOCYTE  MARKERS  IN  SLE  MICE 
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selective loss of suppressor T  cells mediated by natural thymocytotoxic antibodies. In 
BXSB mice there was also a decrease in numbers of T  cells with age. In contrast, old 
MRL/I  mice of both sexes manifest extremely high frequencies and  numbers of T 
cells. MRL/1 mice, which have the genotype lpr/lpr, exhibit massive lymphadenop- 
athy beginning at 8 wk old and progressing by 16 wk old to over 100 times the weight 
of control  lymph  nodes  (6,  7).  Attempts  by  Murphy  et  al.  (6,  24)  and  ourselves 
(unpublished)  to transplant  enlarged lymph nodes to  find evidence of malignancy 
have failed. However, these proliferating T  cells may contribute to the autoimmune 
disease  process, because the  lpr minus  congenie MRL/n  mice develop the  disease 
much later in life than the MRL/1 mice. 
We also studied the distribution of the Ly-bearing cells in young and old MRL/I 
mice. T  cells expressing Lyl are inducers or helpers; T  cells expressing Ly23 are killer 
and suppressor cells, and T  cells expressing Ly123 represent an intermediate pool of 
T  cells that is uncommitted to helper or suppressor function but express regulating 
signals on both Lyl and Ly23 subsets (19). Gershon (53) and Cantor et al. (19) showed 
that Ly 123 regulatory T cells decline in aging NZB mice and suggested its relationship 
to autoimmunity. Our MRL/1 mice display a striking drop of the large Ly123  + subset 
of T  cells with age concomitant with massive lymphoproliferation and acquisition of 
Ly null cells which represent the bulk of the 0  ÷ cells.  As the inability to lyse cells in 
a  direct cytotoxicity assay may be a  reflection of low antigen expression  (18),  our 
observations do not imply that these null cells are necessarily devoid of Ly antigens. 
The  data  do  indicate,  however,  a  significant  difference in  the  lymph  node  cells 
obtained from young and old MRL/I mice. Because Lyl  + cells are ='40% of the 0  +- 
cells in C57BL/6, and in the old MRL/1 the Lyl  + cells are 44% of the 0+-cells,  one 
may suggest that the Ly null cells descend from the Ly123  + subset. This extremely 
interesting hypothesis suggests that  in T-cell ontogeny, at least some of the Ly123  + 
cells eventually differentiate into null cells.  Therefore, lymphoproliferation in these 
mice may stem from the fact that precursor (probably 0  +, Ly123  ÷) cells are released 
to proliferate and differentiate to 0  +-, Ly null cell. 
Finally, we examined the expression of Ia antigens coded by the I-J subregion of THEOFILOPOULOS  ET  AL. 
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the H-2 gene complex on isolated splenic T  cells from BXSB and MRL/I mice and 
histocompatible normal mice. Apparently Ia antigens coded by the I-J subregion are 
expressed on suppressor T  cells (6) and concanavalin A-reactive T  cells (54), whereas 
the  Ia  antigens  controlled  by  the  other  subregions  appear  predominately  on  B 
lymphocytes and on helper T  cells (54, 55). Furthermore, the IoJ subregion codes for 
determinants  on  soluble  factors  that  suppress  antibody responses  (56).  Functional 
studies with NZB  ×  W  lymphocytes have suggested a decline with age of suppressor 
T  cells (57). Unfortunately, no antiserum with specificity for I-ja-coded determinants 
was available for phenotypic studies in NZB mice. Nevertheless, our results showed 
no differences between normal  and  two autoimmune strains  (MRL/1 and  BXSB). 
These mice have percentages of I-J  + cells similar to that described by Parish (58)  in 
normal  mice  using  a  rosette procedure.  This  finding  does  not  exclude functional 
abnormalities of suppressor T  cells in mice with  SLE-like syndromes, but perhaps, 
contrary to NZB mice (51, 52), suggest that natural thymocytotoxic antibodies found 
in  BXSB male mice and  to much lesser extent in  MRL/1  mice  (7)  may not  have 
specificity for suppressor T  cells. In MRL/I mice, as noted, we found a decline of the 
Ly23  + subset with age. However, with anti-I-J  k sera we found an increased frequency 
and number of cells bearing Ia antigens controlled by the I-J subregion of the H-2 
complex. These results, taken together, suggest that Ly23  + cells may also proliferate 
in  aged  MRL/1  mice  and  lose  their  Ly  but  retain  their  /-J-controlled  surface 
alloantigens. 
If a parallel can be drawn between our study in mice with SLE-like syndromes and 
the studies  of others  (36,  59-61)  in  humans  with  SLE, then  indeed a  spectrum  of 
abnormalities in T  and B cells and their subsets may be associated with this disease 
process.  Now the role and  the contribution of these defects must  be established by 
using well defined in vitro systems with various subpopulations of T  and B cells as 
well as in vivo cell transfer systems in normal and autoimmune mice. 
Summary 
The frequencies and absolute numbers of B and T  cells in the lymphoid organs of 
five murine  strains  (NZB,  (NZB  X  NZW)F1,  BXSB,  MRL/1,  and  MRL/n)  with 
SLE-like  syndromes  were  examined.  We  assessed  the  frequencies of cells  bearing 
surface Ig, C3d and IgG Fc receptors, and 0-antigen. The sequential expression of Ig 
isotopes on developing B  cells and  the Ig isotypes expressed on adult  B  cells were 
ascertained. In addition, the Ly subsets and the expression of Ia antigens coded for by 
the I-J subregion of the mouse H-2 complex were examined. 530  LYMPHOCYTE  MARKERS  IN SLE  MICE 
TABLE V 
Cells Bearing I-J Subregion-Controlled Antigenic Determinants in Spleens of Normal and Autoimmune Mice 
No. nu-  0  ÷ ceils  No. 0+-cells  Strain*  Age  cleated  cells 
Cells bearing I-J-con- 
trolled determinants 
0  +  Total 
mo  ×  10  -6  %  ×  lO  -6  %  x  lO  -6 
C3H ~  1  48*  42  20  17.7  3.5 
8  140  38  53  7.0  3.7 
MRL/1 ¢2  1  52  41  20  23.2  4.6 
4.5  310  73  226  30.4  68.7 
MRL/n 2  1  50  33  16  12.0  1.9 
8  160  45  72  19.0  13.6 
C57BL/6 ~  1  90  37  33  13.4  4.4 
9  105  34  36  16.7  5.9 
BXSB ~  l  65  60  39  15.7  6.1 
5  215  18  39  16.6  6.4 
BXSB 9  1  58  53  31  20.3  6.2 
8  120  39  47  12.5  5.8 
* Each number represents results obtained with a single pool of three spleens. 
Compared  to  normal, older  mice,  New  Zealand mice  had  low  frequencies and 
absolute numbers of B  cells, BXSB  mice had  a  moderate B-cell proliferation, and 
MRL/1  mice  had  normal  absolute  numbers of  B  cells  but  a  reduced  frequency 
concomitant with a  massive T-cell proliferation. Old New Zealand mice and BXSB 
mice  had  reduced  frequencies and  absolute  numbers of T  cells  compared  to  old 
controls. The developmental Ig-isotype diversity during the  1st wk of age was similar 
in  normal  mice  and  those  with  autoimmune manifestations. Mature  B  cells were 
present in lymphoid organs of New Zealand mice and BXSB mice as evidenced by 
the high frequency of C3d receptor-bearing cells and Ig-isotype expression (high ratio 
of IgM-  to  IgD-bearing cells)  in  adult  spleen  ~ells.  Numbers of IgG  Fc  receptor- 
bearing cells were reduced in autoimmune mice with advanced age and disease. The 
proliferating T  cells in MRL/I mice were found to be 0-antigen positive but Ly null. 
These 0  +-,  Ly  null cells may have arisen from  Ly123  + T  cells.  MRL/1  and BXSB 
mice seemed normal in their content of T  cells bearing Ia antigens coded for by the 
I-J subregion of H-2. Overall, mice with autoimmune manifestations appear to express 
perturbations in T  and  B  cells with  development of disease,  and their patterns of 
change vary from one strain to another. 
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